sunitinib newbury 12.5 mg
newbury pharmaceuticals ab - sunitinibmalat - kapsel, hard - 12.5 mg
sunitinib newbury 25 mg
newbury pharmaceuticals ab - sunitinibmalat - kapsel, hard - 25 mg
dabigatran etexilate accord
accord healthcare s.l.u. - dabigatran etexilate mesilate - venous thromboembolism; arthroplasty, replacement - antithrombotic agents - prevention of venous thromboembolic events.
dabigatran etexilate sandoz 75 mg
sandoz a/s - dabigatraneteksilatmesilat - kapsel, hard - 75 mg
dabigatran etexilate sandoz 150 mg
sandoz a/s - dabigatraneteksilatmesilat - kapsel, hard - 150 mg
entecavir accord
accord healthcare s.l.u. - entecavir - hepatitt b, kronisk - antivirale midler til systemisk bruk - entecavir accord is indicated for the treatment of chronic hepatitis b virus (hbv) infection in adults with: , compensated liver disease and evidence of active viral replication, persistently elevated serum alanine aminotransferase (alt) levels and histological evidence of active inflammation and/or fibrosis. , dekompensert leversykdom. for både kompensert og dekompensert leversykdom, denne indikasjonen er basert på kliniske dataene i nucleoside naive pasienter med hbeag positive og hbeag negativ hbv-infeksjon. med hensyn til pasienter med lamivudin-ildfast hepatitt b. entecavir accord er også indisert for behandling av kronisk hbv-infeksjon i nucleoside naiv paediatric pasienter fra 2 til.
tadalafil accord 20 mg
accord healthcare b.v. - tadalafil - tablett, filmdrasjert - 20 mg
tadalafil accord 10 mg
accord healthcare b.v. - tadalafil - tablett, filmdrasjert - 10 mg
ritonavir accord 100 mg
accord healthcare b.v. - ritonavir - tablett, filmdrasjert - 100 mg
tadalafil accord 5 mg
accord healthcare b.v. - tadalafil - tablett, filmdrasjert - 5 mg